Pasar al contenido principal

PROTEINAS DE UNION A RNA EN TRADUCCION Y METASTASIS

PID2021-127948NB-I00

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal para Impulsar la Investigación Científico-Técnica y su Transferencia
Subprograma Subprograma Estatal de Generación de Conocimiento
Convocatoria Proyectos de I+D+i (Generación de Conocimiento y Retos Investigación)
Año convocatoria 2021
Plan Estatal 2021-2023 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario FUNDACIO CENTRE DE REGULACIO GENOMICA

Resultados relacionados

Resultados totales (Incluyendo duplicados): 10
Encontrada(s) 1 página(s)

Repositorio Digital de la UPF
Publicación Artículo científico (JournalArticle)

The Drosophila RNA binding protein Hrp48 binds a specific RNA sequence of the msl-2 mRNA 3' UTR to regulate translation

  • Lomoschitz, Andrea
  • Meyer, Julia
  • Guitart, Tanit
  • Krepl, Miroslav
  • Lapouge, Karine
  • Hayn, Clara
  • Schweimer, Kristian
  • Simon, Bernd
  • Šponer, Jiří
  • Gebauer, Fátima
  • Hennig, Janosch
Repression of msl-2 mRNA translation is essential for viability of Drosophila melanogaster females to prevent hypertranscription of both X chromosomes. This translational control event is coordinated by the female-specific protein Sex-lethal (Sxl) which recruits the RNA binding proteins Unr and Hrp48 to the 3' untranslated region (UTR) of the msl-2 transcript and represses translation initiation. The mechanism exerted by Hrp48 during translation repression and its interaction with msl-2 are not well understood. Here we investigate the RNA binding specificity and affinity of the tandem RNA recognition motifs of Hrp48. Using NMR spectroscopy, molecular dynamics simulations and isothermal titration calorimetry, we identified the exact region of msl-2 3' UTR recognized by Hrp48. Additional biophysical experiments and translation assays give further insights into complex formation of Hrp48, Unr, Sxl and RNA. Our results show that Hrp48 binds independent of Sxl and Unr downstream of the E and F binding sites of Sxl and Unr to msl-2., We thank the local contacts at DESY Hamburg PETRA-3 (P12 beamline) for support J.Š. and M.K. acknowledge support of the Czech Science Foundation (grant number 23-05639S). F.G. acknowledges support from the Spanish Ministry of Science and Innovation (MCIN) (grant PID2021-127948NB-I00 funded by MCIN/AEI/10.13039/501100011033/FEDER, UE) and the Catalan Agency for Research and Universities (SGR-Cat-2021-01215). J.H. gratefully acknowledges support from the Deutsche Forschungsgemeinschaft (DFG, HE 7291/5-1).
Repositorio Digital de la UPF
Publicación Artículo científico (JournalArticle)

ADAR3 modulates neuronal differentiation and regulates mRNA stability and translation

  • Karlström, Victor
  • Sagredo, Eduardo A.
  • Planells, Jordi
  • Welinder, Charlotte
  • Jungfleisch, Jennifer
  • Barrera Conde, Andrea
  • Engfors, Linus
  • Daniel, Chammiran
  • Gebauer, Fátima
  • Visa, Neus
  • Öhman, Marie
ADAR3 is a catalytically inactive member of the family of adenosine deaminases acting on RNA (ADARs). Here we have investigated its function in the context of the developing mouse brain. The expression of ADAR3 gradually increases throughout embryogenesis and drops after birth. Using primary cortical neurons, we show that ADAR3 is only expressed in a subpopulation of in vitro differentiated neurons, which suggests specific functions rather than being a general regulator of ADAR editing in the brain. The analysis of the ADAR3 interactome suggested a role in mRNA stability and translation, and we show that expression of ADAR3 in a neuronal cell line that is otherwise ADAR3-negative changes the expression and stability of a large number of mRNAs. Notably, we show that ADAR3 associates with polysomes and inhibits translation. We propose that ADAR3 binds to target mRNAs and stabilizes them in non-productive polysome complexes. Interestingly, the expression of ADAR3 downregulates genes related to neuronal differentiation and inhibits neurofilament outgrowth in vitro. In summary, we propose that ADAR3 negatively regulates neuronal differentiation, and that it does so by regulating mRNA stability and translation in an editing-independent manner., Swedish Research Council [dnr.2016-02005, 2018-03823, 2019-03853 to M.Ö., C.D., N.V.]; Carl Trygger's Foundation (to N.V.); V.K. and J.P.R. were supported by the Department of Molecular Biosciences, Wenner-Gren Institute, Stockholm University; E.A.S. was supported by SFO funding from the Faculty of Science at the Stockholm University, O.E. and Edla Johanssons Foundation and Royal Physiographic Society in Lund; Spanish Ministry of Science and Innovation [PGC2018-099697-B-I00 and PID2021-127948NB-I00 to F.G.]; Centro de Excelencia Severo Ochoa [CEX2020-001049-S, MCIN/AEI /10.13039/501100011033]; Generalitat de Catalunya through the CERCA Programme.
Repositorio Digital de la UPF
Publicación Artículo científico (JournalArticle)

CSDE1 intracellular distribution as a biomarker of melanoma prognosis

  • Indacochea Cusirramos, Alberto
  • Guitart, Tanit
  • Boada, Aram
  • Peg, Vicente
  • Quer, Ariadna
  • Laayouni, Hafid, 1968-
  • Condal, Laura
  • Espinosa, Pablo
  • Manzano Mozo, José Luis
  • Gebauer, Fátima
RNA-binding proteins are emerging as critical modulators of oncogenic cell transformation, malignancy and therapy resistance. We have previously found that the RNA-binding protein Cold Shock Domain containing protein E1 (CSDE1) promotes invasion and metastasis of melanoma, the deadliest form of skin cancer and also a highly heterogeneous disease in need of predictive biomarkers and druggable targets. Here, we design a monoclonal antibody useful for IHC in the clinical setting and use it to evaluate the prognosis potential of CSDE1 in an exploratory cohort of 149 whole tissue sections including benign nevi and primary tumors and metastasis from melanoma patients. Contrary to expectations for an oncoprotein, we observed a global decrease in CSDE1 levels with increasing malignancy. However, the CSDE1 cytoplasmic/nuclear ratio exhibited a positive correlation with adverse clinical features of primary tumors and emerged as a robust indicator of progression free survival in cutaneous melanoma, highlighting the potential of CSDE1 as a biomarker of prognosis. Our findings provide a novel feature for prognosis assessment and highlight the intricacies of RNA-binding protein dynamics in cancer progression., A.I. and P.E. were supported by PhD4MD fellowships from the CRG and the Emerald program (Marie Skłodowska-Curie grant agreement 101034290), respectively. This work was supported by the following grants to F.G.: PGC2018-099697-B-I00 and PID2021-127948NB-I00 from the Spanish Ministry of Science and Innovation (MCIN) funded by MCIN/ AEI /10.13039/501100011033/ and by ERDF; “la Caixa” Foundation (ID 100010434) under the Grant LCF/PR/HR17/52150016; the Catalan Agency for Research and Universities (SGR-Cat-2021-01215) and intramural funds from the CRG on emergent translational research. We acknowledge the support of the Spanish Ministry of Science and Innovation through the Centro de Excelencia Severo Ochoa (CEX2020-001049-S, MCIN/AEI /10.13039/501100011033) and the Generalitat de Catalunya through the CERCA programme.
Repositorio Digital de la UPF
Publicación Artículo científico (JournalArticle)

Context-dependent phosphorylation of CSDE1 drives interactions with ribosomes

  • Ciocia, Annagiulia
  • Guitart, Tanit
  • Mestre Farràs, Neus
  • Nogales, Adrià
  • Milenkovic, Ivan
  • Coll, Olga
  • Medina, Rebeca
  • Chiva, Cristina
  • Sabidó Aguadé, Eduard, 1981-
  • Novoa, Eva Maria
  • Gebauer, Fátima
The RNA-binding protein CSDE1 is a key regulator of mRNA stability and translation in a broad spectrum of biological processes. We have previously shown that CSDE1 functions as an oncoprotein promoting invasion and metastasis in melanoma, whereas it behaves as a tumor suppressor promoting cellular senescence in squamous cell carcinoma. The reasons underlying these context-specific behaviors are unknown. To identify melanoma-specific vulnerabilities, we have compared CSDE1 protein isoforms and post-translational modifications in melanoma cells, keratinocytes, and melanocytic cells of different tumorigenic potential. By combining long-read Nanopore sequencing with two-dimensional gel electrophoresis and transcriptome analysis, we identify one major isoform expressed in melanoma cells and patient samples. This isoform is phosphorylated early during cellular transformation, correlating with changes in its subcellular localization. We provide extensive interactome analysis of mammalian CSDE1, showing increased interactions with ribosomes in melanoma cells compared to healthy melanocytes. Importantly, interactions of CSDE1 with the ribosome are promoted by CSDE1 phosphorylation. Our data uncover a specific feature of melanoma cells that could be harnessed for therapeutic intervention., This publication is based on research supported by the Melanoma Research Alliance award (https://doi.org/10.48050/pc.gr.143718) (Established Investigator Award 826530) to F.G., the Spanish Ministry of Science and Innovation (MCIN) (grants PID2021-127948NB-I00 to F.G. and PID2021-128193NB-I00 to E.M.N. funded by MCIN/AEI/10.13039/501100011033/FEDER, UE), the European Union's Horizon Europe (ERC Starting Grant 101042103 to E.M.N.), and the Departament de Recerca i Universitats de la Generalitat de Catalunya via the Catalan Agency for Research and Universities under AGAUR grants 2021-SGR2021-01215 to F.G. and 2021-SGR2021-01301 to E.M.N. A.C. was supported by PRE2019-087927 FPI contract from MCIN cofunded by MCIN/AEI/10.13039/501100011033 and FSE+. I.M. was supported by INPhINIT, "la Caixa" Doctoral Fellowship Programme (ID 100010434, fellowship code LCF/BQ/DI18/11660028). This project has received funding from the European Union's Horizon 2020 research and innovation program under the Marie Sklodowska-Curie grant agreement no. 713673. We also acknowledge support of MCIN through the Centro de Excelencia Severo Ochoa (CEX2020-001049-S, MCIN/AEI/10.13039/501100011033) and the Generalitat de Catalunya through the CERCA program.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

CSDE1 Intracellular Distribution as a Biomarker of Melanoma Prognosis

  • Indacochea, Alberto
  • Guitart, Tanit
  • Boada, Aram
  • Peg, Vicente
  • Quer, Ariadna
  • Laayouni, Hafid
  • Condal, Laura
  • Espinosa, Pablo
  • Manzano, José Luis
  • Gebauer, Fátima
© 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/)., RNA-binding proteins are emerging as critical modulators of oncogenic cell transformation, malignancy and therapy resistance. We have previously found that the RNA-binding protein Cold Shock Domain containing protein E1 (CSDE1) promotes invasion and metastasis of melanoma, the deadliest form of skin cancer and also a highly heterogeneous disease in need of predictive biomarkers and druggable targets. Here, we design a monoclonal antibody useful for IHC in the clinical setting and use it to evaluate the prognosis potential of CSDE1 in an exploratory cohort of 149 whole tissue sections including benign nevi and primary tumors and metastasis from melanoma patients. Contrary to expectations for an oncoprotein, we observed a global decrease in CSDE1 levels with increasing malignancy. However, the CSDE1 cytoplasmic/nuclear ratio exhibited a positive correlation with adverse clinical features of primary tumors and emerged as a robust indicator of progression free survival in cutaneous melanoma, highlighting the potential of CSDE1 as a biomarker of prognosis. Our findings provide a novel feature for prognosis assessment and highlight the intricacies of RNA-binding protein dynamics in cancer progression., A.I. and P.E. were supported by PhD4MD fellowships from the CRG and the Emerald program (Marie Skłodowska-Curie grant agreement 101034290), respectively. This work was supported by the following grants to F.G.: PGC2018-099697-B-I00 and PID2021-127948NB-I00 from the Spanish Ministry of Science and Innovation (MCIN) funded by MCIN/ AEI /10.13039/501100011033/ and by ERDF; “la Caixa” Foundation (ID 100010434) under the Grant LCF/PR/HR17/52150016; the Catalan Agency for Research and Universities (SGR-Cat-2021-01215) and intramural funds from the CRG on emergent translational research. We acknowledge the support of the Spanish Ministry of Science and Innovation through the Centro de Excelencia Severo Ochoa (CEX2020-001049-S, MCIN/AEI /10.13039/501100011033) and the Generalitat de Catalunya through the CERCA programme., With funding from the Spanish government through the ‘Severo Ochoa Centre of Excellence’ accreditation (CEX2020-001049-S)., Peer reviewed
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

The Drosophila RNA binding protein Hrp48 binds a specific RNA sequence of the msl-2 mRNA 3' UTR to regulate translation

  • Lomoschitz, Andrea
  • Meyer, Julia
  • Guitart, Tanit
  • Krepl, Miroslav
  • Lapouge, Karine
  • Hayn, Clara
  • Schweimer, Kristian
  • Simon, Bernd
  • Šponer, Jiří
  • Gebauer, Fátima
  • Hennig, Janosch
Repression of msl-2 mRNA translation is essential for viability of Drosophila melanogaster females to prevent hypertranscription of both X chromosomes. This translational control event is coordinated by the female-specific protein Sex-lethal (Sxl) which recruits the RNA binding proteins Unr and Hrp48 to the 3' untranslated region (UTR) of the msl-2 transcript and represses translation initiation. The mechanism exerted by Hrp48 during translation repression and its interaction with msl-2 are not well understood. Here we investigate the RNA binding specificity and affinity of the tandem RNA recognition motifs of Hrp48. Using NMR spectroscopy, molecular dynamics simulations and isothermal titration calorimetry, we identified the exact region of msl-2 3' UTR recognized by Hrp48. Additional biophysical experiments and translation assays give further insights into complex formation of Hrp48, Unr, Sxl and RNA. Our results show that Hrp48 binds independent of Sxl and Unr downstream of the E and F binding sites of Sxl and Unr to msl-2., We thank the local contacts at DESY Hamburg PETRA-3 (P12 beamline) for support J.Š. and M.K. acknowledge support of the Czech Science Foundation (grant number 23-05639S). F.G. acknowledges support from the Spanish Ministry of Science and Innovation (MCIN) (grant PID2021-127948NB-I00 funded by MCIN/AEI/10.13039/501100011033/FEDER, UE) and the Catalan Agency for Research and Universities (SGR-Cat-2021-01215). J.H. gratefully acknowledges support from the Deutsche Forschungsgemeinschaft (DFG, HE 7291/5-1).
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Context-dependent phosphorylation of CSDE1 drives interactions with ribosomes

  • Ciocia, Annagiulia
  • Guitart, Tanit
  • Mestre Farràs, Neus
  • Nogales, Adrià
  • Milenkovic, Ivan
  • Coll, Olga
  • Medina, Rebeca
  • Chiva, Cristina
  • Sabidó Aguadé, Eduard, 1981-
  • Novoa, Eva Maria
  • Gebauer, Fátima
The RNA-binding protein CSDE1 is a key regulator of mRNA stability and translation in a broad spectrum of biological processes. We have previously shown that CSDE1 functions as an oncoprotein promoting invasion and metastasis in melanoma, whereas it behaves as a tumor suppressor promoting cellular senescence in squamous cell carcinoma. The reasons underlying these context-specific behaviors are unknown. To identify melanoma-specific vulnerabilities, we have compared CSDE1 protein isoforms and post-translational modifications in melanoma cells, keratinocytes, and melanocytic cells of different tumorigenic potential. By combining long-read Nanopore sequencing with two-dimensional gel electrophoresis and transcriptome analysis, we identify one major isoform expressed in melanoma cells and patient samples. This isoform is phosphorylated early during cellular transformation, correlating with changes in its subcellular localization. We provide extensive interactome analysis of mammalian CSDE1, showing increased interactions with ribosomes in melanoma cells compared to healthy melanocytes. Importantly, interactions of CSDE1 with the ribosome are promoted by CSDE1 phosphorylation. Our data uncover a specific feature of melanoma cells that could be harnessed for therapeutic intervention., This publication is based on research supported by the Melanoma Research Alliance award (https://doi.org/10.48050/pc.gr.143718) (Established Investigator Award 826530) to F.G., the Spanish Ministry of Science and Innovation (MCIN) (grants PID2021-127948NB-I00 to F.G. and PID2021-128193NB-I00 to E.M.N. funded by MCIN/AEI/10.13039/501100011033/FEDER, UE), the European Union's Horizon Europe (ERC Starting Grant 101042103 to E.M.N.), and the Departament de Recerca i Universitats de la Generalitat de Catalunya via the Catalan Agency for Research and Universities under AGAUR grants 2021-SGR2021-01215 to F.G. and 2021-SGR2021-01301 to E.M.N. A.C. was supported by PRE2019-087927 FPI contract from MCIN cofunded by MCIN/AEI/10.13039/501100011033 and FSE+. I.M. was supported by INPhINIT, "la Caixa" Doctoral Fellowship Programme (ID 100010434, fellowship code LCF/BQ/DI18/11660028). This project has received funding from the European Union's Horizon 2020 research and innovation program under the Marie Sklodowska-Curie grant agreement no. 713673. We also acknowledge support of MCIN through the Centro de Excelencia Severo Ochoa (CEX2020-001049-S, MCIN/AEI/10.13039/501100011033) and the Generalitat de Catalunya through the CERCA program.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

CSDE1 intracellular distribution as a biomarker of melanoma prognosis

  • Indacochea Cusirramos, Alberto
  • Guitart, Tanit
  • Boada, Aram
  • Peg, Vicente
  • Quer, Ariadna
  • Laayouni, Hafid, 1968-
  • Condal, Laura
  • Espinosa, Pablo
  • Manzano Mozo, José Luis
  • Gebauer, Fátima
RNA-binding proteins are emerging as critical modulators of oncogenic cell transformation, malignancy and therapy resistance. We have previously found that the RNA-binding protein Cold Shock Domain containing protein E1 (CSDE1) promotes invasion and metastasis of melanoma, the deadliest form of skin cancer and also a highly heterogeneous disease in need of predictive biomarkers and druggable targets. Here, we design a monoclonal antibody useful for IHC in the clinical setting and use it to evaluate the prognosis potential of CSDE1 in an exploratory cohort of 149 whole tissue sections including benign nevi and primary tumors and metastasis from melanoma patients. Contrary to expectations for an oncoprotein, we observed a global decrease in CSDE1 levels with increasing malignancy. However, the CSDE1 cytoplasmic/nuclear ratio exhibited a positive correlation with adverse clinical features of primary tumors and emerged as a robust indicator of progression free survival in cutaneous melanoma, highlighting the potential of CSDE1 as a biomarker of prognosis. Our findings provide a novel feature for prognosis assessment and highlight the intricacies of RNA-binding protein dynamics in cancer progression., A.I. and P.E. were supported by PhD4MD fellowships from the CRG and the Emerald program (Marie Skłodowska-Curie grant agreement 101034290), respectively. This work was supported by the following grants to F.G.: PGC2018-099697-B-I00 and PID2021-127948NB-I00 from the Spanish Ministry of Science and Innovation (MCIN) funded by MCIN/ AEI /10.13039/501100011033/ and by ERDF; “la Caixa” Foundation (ID 100010434) under the Grant LCF/PR/HR17/52150016; the Catalan Agency for Research and Universities (SGR-Cat-2021-01215) and intramural funds from the CRG on emergent translational research. We acknowledge the support of the Spanish Ministry of Science and Innovation through the Centro de Excelencia Severo Ochoa (CEX2020-001049-S, MCIN/AEI /10.13039/501100011033) and the Generalitat de Catalunya through the CERCA programme.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

ADAR3 modulates neuronal differentiation and regulates mRNA stability and translation

  • Karlström, Victor
  • Sagredo, Eduardo A.
  • Planells, Jordi
  • Welinder, Charlotte
  • Jungfleisch, Jennifer
  • Barrera Conde, Andrea
  • Engfors, Linus
  • Daniel, Chammiran
  • Gebauer, Fátima
  • Visa, Neus
  • Öhman, Marie
ADAR3 is a catalytically inactive member of the family of adenosine deaminases acting on RNA (ADARs). Here we have investigated its function in the context of the developing mouse brain. The expression of ADAR3 gradually increases throughout embryogenesis and drops after birth. Using primary cortical neurons, we show that ADAR3 is only expressed in a subpopulation of in vitro differentiated neurons, which suggests specific functions rather than being a general regulator of ADAR editing in the brain. The analysis of the ADAR3 interactome suggested a role in mRNA stability and translation, and we show that expression of ADAR3 in a neuronal cell line that is otherwise ADAR3-negative changes the expression and stability of a large number of mRNAs. Notably, we show that ADAR3 associates with polysomes and inhibits translation. We propose that ADAR3 binds to target mRNAs and stabilizes them in non-productive polysome complexes. Interestingly, the expression of ADAR3 downregulates genes related to neuronal differentiation and inhibits neurofilament outgrowth in vitro. In summary, we propose that ADAR3 negatively regulates neuronal differentiation, and that it does so by regulating mRNA stability and translation in an editing-independent manner., Swedish Research Council [dnr.2016-02005, 2018-03823, 2019-03853 to M.Ö., C.D., N.V.]; Carl Trygger's Foundation (to N.V.); V.K. and J.P.R. were supported by the Department of Molecular Biosciences, Wenner-Gren Institute, Stockholm University; E.A.S. was supported by SFO funding from the Faculty of Science at the Stockholm University, O.E. and Edla Johanssons Foundation and Royal Physiographic Society in Lund; Spanish Ministry of Science and Innovation [PGC2018-099697-B-I00 and PID2021-127948NB-I00 to F.G.]; Centro de Excelencia Severo Ochoa [CEX2020-001049-S, MCIN/AEI /10.13039/501100011033]; Generalitat de Catalunya through the CERCA Programme.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

CSDE1 Intracellular Distribution as a Biomarker of Melanoma Prognosis

  • Indacochea, Alberto
  • Guitart, Tanit|||0000-0003-2992-9895
  • Boada, Aram|||0000-0001-9809-5308
  • Peg, Vicente|||0000-0002-5203-6166
  • Quer, Ariadna
  • Laayouni, Hafid|||0000-0003-1297-5078
  • Condal, Laura
  • Espinosa, Pablo|||0000-0003-0692-7301
  • Manzano, José Luís
  • Gebauer, Fátima
RNA-binding proteins are emerging as critical modulators of oncogenic cell transformation, malignancy and therapy resistance. We have previously found that the RNA-binding protein Cold Shock Domain containing protein E1 (CSDE1) promotes invasion and metastasis of melanoma, the deadliest form of skin cancer and also a highly heterogeneous disease in need of predictive biomarkers and druggable targets. Here, we design a monoclonal antibody useful for IHC in the clinical setting and use it to evaluate the prognosis potential of CSDE1 in an exploratory cohort of 149 whole tissue sections including benign nevi and primary tumors and metastasis from melanoma patients. Contrary to expectations for an oncoprotein, we observed a global decrease in CSDE1 levels with increasing malignancy. However, the CSDE1 cytoplasmic/nuclear ratio exhibited a positive correlation with adverse clinical features of primary tumors and emerged as a robust indicator of progression free survival in cutaneous melanoma, highlighting the potential of CSDE1 as a biomarker of prognosis. Our findings provide a novel feature for prognosis assessment and highlight the intricacies of RNA-binding protein dynamics in cancer progression.